These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35288428)

  • 1. Refractory focal segmental glomerulosclerosis caused by Alport syndrome detected by genetic testing after three decades.
    Oda Y; Sawa N; Nozu K; Ubara Y
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35288428
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Zhang P; Zhuo L; Zou Y; Li G; Peng K
    Clin Nephrol; 2019 Aug; 92(2):98-102. PubMed ID: 31198170
    [No Abstract]   [Full Text] [Related]  

  • 3. COL4A3 mutation is an independent risk factor for poor prognosis in children with Alport syndrome.
    Ozdemir G; Gulhan B; Atayar E; Saygılı S; Soylemezoglu O; Ozcakar ZB; Eroglu FK; Candan C; Demir BK; Soylu A; Yüksel S; Alpay H; Agbas A; Duzova A; Hayran M; Ozaltin F; Topaloglu R
    Pediatr Nephrol; 2020 Oct; 35(10):1941-1952. PubMed ID: 32394188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis.
    Papazachariou L; Papagregoriou G; Hadjipanagi D; Demosthenous P; Voskarides K; Koutsofti C; Stylianou K; Ioannou P; Xydakis D; Tzanakis I; Papadaki A; Kallivretakis N; Nikolakakis N; Perysinaki G; Gale DP; Diamantopoulos A; Goudas P; Goumenos D; Soloukides A; Boletis I; Melexopoulou C; Georgaki E; Frysira E; Komianou F; Grekas D; Paliouras C; Alivanis P; Vergoulas G; Pierides A; Daphnis E; Deltas C
    Clin Genet; 2017 Nov; 92(5):517-527. PubMed ID: 28632965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Mutation in LMX1B (p.Pro219Ala) Causes Focal Segmental Glomerulosclerosis with Alport Syndrome-like Phenotype.
    Oe Y; Mishima E; Mori T; Okamoto K; Honkura Y; Nagasawa T; Yoshida M; Sato H; Suzuki J; Ikeda R; Sohara E; Uchida S; Katori Y; Miyazaki M
    Intern Med; 2021 Sep; 60(18):2991-2996. PubMed ID: 33814499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted exome sequencing integrated with clinicopathological information reveals novel and rare mutations in atypical, suspected and unknown cases of Alport syndrome or proteinuria.
    Chatterjee R; Hoffman M; Cliften P; Seshan S; Liapis H; Jain S
    PLoS One; 2013; 8(10):e76360. PubMed ID: 24130771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic heterogeneity in females with X-linked Alport syndrome.
    Allred SC; Weck KE; Gasim A; Mottl AK
    Clin Nephrol; 2015 Nov; 84(5):296-300. PubMed ID: 26249550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney Injury by Variants in the
    Frese J; Kettwig M; Zappel H; Hofer J; Gröne HJ; Nagel M; Sunder-Plassmann G; Kain R; Neuweiler J; Gross O
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30691124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exome analysis resolves differential diagnosis of familial kidney disease and uncovers a potential confounding variant.
    Gibson J; Gilbert RD; Bunyan DJ; Angus EM; Fowler DJ; Ennis S
    Genet Res (Camb); 2013 Dec; 95(6):165-73. PubMed ID: 24472419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COL4A gene variants are common in children with hematuria and a family history of kidney disease.
    Rheault MN; McLaughlin HM; Mitchell A; Blake LE; Devarajan P; Warady BA; Gibson KL; Lieberman KV
    Pediatr Nephrol; 2023 Nov; 38(11):3625-3633. PubMed ID: 37204491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.
    Kamiyoshi N; Nozu K; Fu XJ; Morisada N; Nozu Y; Ye MJ; Imafuku A; Miura K; Yamamura T; Minamikawa S; Shono A; Ninchoji T; Morioka I; Nakanishi K; Yoshikawa N; Kaito H; Iijima K
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1441-1449. PubMed ID: 27281700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical Alport syndrome associated with a novel COL4A5 mutation.
    Höpker K; Liebau MC; Friederichsohn C; Waldherr R; Benzing T
    Clin Nephrol; 2009 Mar; 71(3):321-5. PubMed ID: 19281745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carriers of Autosomal Recessive Alport Syndrome with Thin Basement Membrane Nephropathy Presenting as Focal Segmental Glomerulosclerosis in Later Life.
    Deltas C; Savva I; Voskarides K; Papazachariou L; Pierides A
    Nephron; 2015; 130(4):271-80. PubMed ID: 26201269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxypropyl-β-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis.
    Mitrofanova A; Molina J; Varona Santos J; Guzman J; Morales XA; Ducasa GM; Bryn J; Sloan A; Volosenco I; Kim JJ; Ge M; Mallela SK; Kretzler M; Eddy S; Martini S; Wahl P; Pastori S; Mendez AJ; Burke GW; Merscher S; Fornoni A
    Kidney Int; 2018 Dec; 94(6):1151-1159. PubMed ID: 30301568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
    Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
    Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial focal segmental glomerulosclerosis with Alport-like glomerular basement changes caused by paired box protein 2 gene variant.
    Yamada Y; Yokoyama H; Kinoshita R; Kitamoto K; Kawaba Y; Okada S; Horie T; Nagano C; Nozu K; Namba N
    CEN Case Rep; 2024 Jun; 13(3):204-208. PubMed ID: 37897632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis.
    Pierides A; Voskarides K; Athanasiou Y; Ioannou K; Damianou L; Arsali M; Zavros M; Pierides M; Vargemezis V; Patsias C; Zouvani I; Elia A; Kyriacou K; Deltas C
    Nephrol Dial Transplant; 2009 Sep; 24(9):2721-9. PubMed ID: 19357112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the ocular features in Pierson and Alport syndrome: a case report and literature review.
    Gooley K; Williams P; Mack H; Zhu V; Langsford D; Pianta T; Barit D; Mahmood K; Savige J
    Ophthalmic Genet; 2023 Oct; 44(5):417-422. PubMed ID: 37537573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis.
    Malone AF; Phelan PJ; Hall G; Cetincelik U; Homstad A; Alonso AS; Jiang R; Lindsey TB; Wu G; Sparks MA; Smith SR; Webb NJ; Kalra PA; Adeyemo AA; Shaw AS; Conlon PJ; Jennette JC; Howell DN; Winn MP; Gbadegesin RA
    Kidney Int; 2014 Dec; 86(6):1253-9. PubMed ID: 25229338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.